冷藏血小板用于预防性输注的争议
美国食品药品监督管理局近期批准14天冷藏血小板用于出血患者,此政策逆转了1970年代因健康人循环时间短而停用冷藏血小板的做法。本文综述冷藏血小板历史、室温血小板临床试验数据及血小板计数作为输注阈值的争议,认为冷藏血小板用于预防性输注看似反直觉,但现有数据提示适应症扩展可能更有前景。
要点
- 美国食品药品监督管理局批准14天冷藏血小板用于出血患者,部分医院冷藏血小板将成为唯一可用的血小板。
- 低增生性血小板减少症患者预防性输注冷藏血小板是否获益目前尚不清楚。
- PLADO试验中晨间血小板计数与出血事件相关性差,提示红细胞、凝血因子和血管健康等因素可能参与。
核心结论
- 冷藏血小板用于预防性输注看似反直觉,但仔细审视现有数据,适应症扩展可能更有前景。
研究设计与样本
- 本文为观点文章,回顾冷藏血小板历史及停用原因,聚焦近期室温储存血小板的临床试验数据,并综述血小板计数作为输注阈值的问题。
主要发现
- 美国食品药品监督管理局近期批准14天冷藏血小板用于出血患者,此政策逆转了1970年代因健康人循环时间短而停用冷藏血小板的做法。
- 在部分美国医院,冷藏血小板将成为唯一可用的血小板。
- 近期使用室温储存血小板的临床试验中,血液和肿瘤疾病患者的输注间隔可短至每天1次,与冷藏血小板预期达到的效果非常相似。
- PLADO试验中晨间血小板计数与出血事件仅呈弱相关性,提示红细胞、凝血因子和血管健康等其他因素可能是原因。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The US Food and Drug Administration recently licensed 14-day cold-stored platelets for bleeding patients. This policy change represents a reversal from the 1970s when cold-stored platelets were discontinued because of their short circulation time in healthy humans. This change will increase their availability in US hospitals with large trauma populations and in remote and rural settings in the United States. In some of these hospitals, cold-stored platelets will be the only platelets available. It is currently unclear whether patients with hypoproliferative thrombocytopenia who need platelet transfusion for prophylaxis benefit from cold-stored platelets. However, it is noteworthy that in recent clinical trials using room temperature-stored platelets, the transfusion interval in patients with hematologic and oncologic conditions can be as short as 1 transfusion per day, very similar to what one would expect to achieve with cold-stored platelets. Furthermore, the emphasis on the posttransfusion count increment and the platelet count as a transfusion trigger per se is questionable. In the PLADO trial, there was only a poor correlation between the morning platelet count and bleeding events, implicating other factors, such as red blood cells, coagulation factors, and vascular health, as possible culprits. In this perspective article, we review the history of cold platelets and the reason for their discontinuation, focus on recent clinical trial data using room temperature-stored platelets, and review the platelet count as a transfusion trigger. Overall, using cold platelets for prophylaxis may seem counterintuitive, but a closer look at the available data suggests that the indication expansion may hold more promise.
引用
- Stolla M, Cap AP, Spinella PC, et al. Chilling controversy: cold-stored platelets for prophylactic transfusions. Blood. 2025. PMID: 40789020. doi:10.1182/blood.2025029252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。